Sivik Global Healthcare LLC Grows Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)

Sivik Global Healthcare LLC grew its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 30.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 250,000 shares of the health services provider's stock after purchasing an additional 57,657 shares during the quarter. Select Medical makes up about 2.5% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 20th biggest position. Sivik Global Healthcare LLC owned 0.19% of Select Medical worth $5,875,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in shares of Select Medical by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 12,005,302 shares of the health services provider's stock worth $303,374,000 after acquiring an additional 64,373 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Select Medical by 3.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,387,202 shares of the health services provider's stock valued at $35,055,000 after purchasing an additional 43,776 shares during the last quarter. Deutsche Bank AG grew its stake in shares of Select Medical by 1,015.2% during the 3rd quarter. Deutsche Bank AG now owns 553,306 shares of the health services provider's stock valued at $13,982,000 after buying an additional 503,692 shares during the period. Clough Capital Partners L P increased its holdings in shares of Select Medical by 16.9% during the 3rd quarter. Clough Capital Partners L P now owns 348,900 shares of the health services provider's stock worth $8,817,000 after buying an additional 50,400 shares during the last quarter. Finally, Rhumbline Advisers raised its position in shares of Select Medical by 0.9% in the 3rd quarter. Rhumbline Advisers now owns 319,642 shares of the health services provider's stock worth $8,077,000 after buying an additional 2,926 shares during the period. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Stock Up 1.3 %


NYSE:SEM traded up $0.37 on Tuesday, reaching $28.36. The stock had a trading volume of 520,474 shares, compared to its average volume of 561,906. Select Medical Holdings Co. has a 12-month low of $21.28 and a 12-month high of $33.51. The stock has a market cap of $3.64 billion, a P/E ratio of 14.92, a price-to-earnings-growth ratio of 1.08 and a beta of 1.37. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.32. The company has a 50-day moving average of $28.26 and a 200 day moving average of $25.80.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Friday, February 23rd. The health services provider reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Select Medical had a return on equity of 16.93% and a net margin of 3.65%. The company had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.22 EPS. Select Medical's revenue for the quarter was up 4.9% compared to the same quarter last year. On average, research analysts predict that Select Medical Holdings Co. will post 2.03 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 13th. Stockholders of record on Friday, March 1st were given a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 1.76%. The ex-dividend date was Thursday, February 29th. Select Medical's payout ratio is currently 26.18%.

Insider Activity

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the business's stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $26.00, for a total value of $1,300,000.00. Following the completion of the sale, the chairman now directly owns 6,789,668 shares of the company's stock, valued at $176,531,368. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 17.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Benchmark restated a "buy" rating and issued a $39.00 price objective on shares of Select Medical in a report on Friday, April 12th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, March 22nd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Select Medical presently has a consensus rating of "Moderate Buy" and an average target price of $34.40.

Check Out Our Latest Report on Select Medical

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Select Medical right now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: